Talis Biomedical Corporation

TLIS | NASDAQ | 0 Sledující

$1.45

16.00%

$0.20

Sledovat

Overview Metrics Financials

Breakdown	12/31/2023 USD	12/31/2022 USD	12/31/2021 USD
Total revenue	412 -88.72%	3,652 -	0 -
Cost of revenue	41 -99.51%	8,391 +220.14%	2,621 -
Gross profit	371 +107.83%	-4,739 -80.81%	-2,621 -
Operating expense	67,186 -39.14%	110,400 -42.44%	191,816 -
Operating income	-66,815 +41.97%	-115,139 +39.97%	-191,816 -
Pretax Income	-62,007 +45.13%	-113,012 +41.15%	-192,036 -
Tax Provision	0 +100.00%	-2,127 -34.79%	-1,578 -
Net income	-62,007 +44.08%	-110,885 +41.78%	-190,458 -
EPS	-34.12 +45.36%	-62.45 +50.49%	-126.13 -
Diluted EPS	-34.12 +45.36%	-62.45 +50.49%	-126.13 -
Average Shares	1,818 +2.36%	1,776 +17.59%	1,510 -
Diluted Average Shares	1,818 +2.36%	1,776 +17.59%	1,510 -
EBIT	-66,815 +41.97%	-115,139 -	0 -
EBITDA	-66,045 +37.87%	-106,309 +44.58%	-191,816 -

Soubory cookie používáme ke zlepšení prohlížení na webu.